Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | LGALS3 | P17931 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.41 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.41 |
| ▸ | CD69 | Q07108 | 1/20 | 0.38 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.38 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.37 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.36 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19521448 | 1.00 | MAPK1 (0.52) | MAPK1LGALS3ALDH1A1THRBKDM4E | |
| SCHEMBL21067800 | 1.00 | MAPK1 (0.52) | MAPK1LGALS3ALDH1A1THRBKDM4E | |
| SCHEMBL4258624 | 1.00 | MAPK1 (0.52) | MAPK1LGALS3ALDH1A1THRBKDM4E | |
| SCHEMBL4322755 | 1.00 | MAPK1 (0.52) | MAPK1LGALS3ALDH1A1THRBKDM4E | |
| SCHEMBL30694316 | 1.00 | MAPK1 (0.52) | MAPK1LGALS3ALDH1A1THRBKDM4E | |
| SCHEMBL30089312 | 0.91 | LGALS3 (0.54) | MAPK1LGALS3ALDH1A1THRBLGALS8 | |
| SCHEMBL29535303 | 0.90 | MAPK1 (0.53) | MAPK1LGALS3ALDH1A1THRBKDM4E | |
| SCHEMBL29535351 | 0.90 | MAPK1 (0.53) | MAPK1LGALS3ALDH1A1THRBKDM4E | |
| SCHEMBL30694301 | 0.89 | MAPK1 (0.62) | MAPK1LGALS3ALDH1A1THRBKDM4E | |
| SCHEMBL29535436 | 0.89 | MAPK1 (0.62) | MAPK1LGALS3ALDH1A1THRBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | NEMIS TECHNOLOGIES AG (CH) | 2021-07-15 | — | — | US | claimed |
| US-20250121071-A1 | REAGENTS AND METHODS FOR PREPARING DERIVATIZED RNA MOLECULES AND METHODS OF USE THEREOF | BROAD INST INC (US) | 2025-04-17 | — | — | US | disclosed |
| EP-4525920-A1 | REAGENTS AND METHODS FOR PREPARING DERIVATIZED RNA MOLECULES AND METHODS OF USE THEREOF | The Broad Institute, Inc. (US) | 2025-03-26 | — | — | EP | disclosed |
| WO-2023225660-A1 | REAGENTS AND METHODS FOR PREPARING DERIVATIZED RNA MOLECULES AND METHODS OF USE THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| CN-110542728-B | Reagents and methods for screening MPS I, II, IIIA, IIIB, IVA, VI and VII | 华盛顿大学商业中心 | 2022-05-24 | — | — | CN | disclosed |
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | NEMIS TECHNOLOGIES AG (CH) | 2021-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | VEGFA, GUSB, NR2E3 | MAPK1 3795/4885LGALS3 469/4885ALDH1A1 297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.